1. Effects of skeletal size of the lumbar apine on areal bone density， volumetric bone density， and the diagnosis of osteoporosis in postmenopausal women in China 1
2.Microcracks： an alternative index for evaluating bone biomechanical quality 9
3.Effects of 17β -Estradiol on the Expression of Matrix Metalloproteinase-1， -2 and Tissue Inhibitor of Metal loproteinase-1 in Human Osteoblast-like Cells Cultures 18
4.Recombinant matrix metalloproteinase-14 catalytic domain induces apoptosis in human osteoblastic SaOS-2 cells 23
5.Comparison of the effects of 17β -E2 and progesterone on the expression on osteoprotegerin in hormal human osetoblast-like cells 29
6.Effects of l 7b-estradiol on the expression of nembrane-type matrix metalloproteinase-1 （MT1-MMP） and matrix metal loproteinase-2 （MMP-2） in human osteoblastic MG-63 cell cultures 35
7.Glutamic aeid decarboxylase 65 autoantibody levels discriminate twosubtypes of latent autoimmune dlabetes in adults 41
8.Correlation Between Bone Mineral Density and Sexual Hormones in Healthy Chinese Women.Journal of Environmental Pathology 46
9.Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in mainland Chinese women and the diagnosis of osteoporosis 49
10.Parathyroid hormone inhibits the expression of membrane-type matrix metal loproteinase-1 （MT1-MMP） in osteoblast-like MG-63 cells 58
11.The effect of low dose nylestriol-levonorgestrel replacement therapy on bone mineral density in women with postmenopausal osteoporosis 65
12.Establishment and evaluation of bone mineral density reference databases appropriate for diagnosis and evaluation of osteoporosis in Chinese women 75
13.1α，25-dihydroxyvitamin D3 regulates the expression of membrane-type matrix metal loproteinase-1 in normal human osteoblast-like cells 84
14.Effects of estriol on the proliferation and differentiation of human osteoblastic MG-63 cells 94
15.Age-related variation in quantitative ultrasound at the tibia and prevalence of osteoporosis in native Chinese women 103
16.Membrane-type matrix metalloproteinase-1 （MTl-MMP） is down-regulated in estrogen-deficient rat osteoblast in vivo 109
17.Age-related bone mineral density，accumulated bone loss rate and prevalence of osteoporosis at multiple skeletal sites in Chinese women 114
18.Progesterone differentially regulates the membrane-type matrix metal loproteinase-1（MTl-MMP） compartment of pro MMP-2 activation in MG-63 cells 122
19.Bone mineral density differences at the femoral neck and Ward’s triangle： a comparison study on the reference data between Chinese and Caucasian women 128
20.Progesterone upregulates TGF-6 isoforms （β1，β2andβ3） expression in normal human osteoblast-line cells 132
21.A comparison study of the reference curves of bone mineral density at different skeletal sites in native Chinese， Japanese， and American Caucasian women 138
22.Thomas Dyrberg.Diagnostic role of antibodies to glutamic acid decarboxylase in latent autoimmune diabetes mellitus in adults 149
23.用三次回归模型建立女性多骨骼部位骨密度参考数据库及其应用评价 153
24.女性腰椎峰值骨量与骨骼大小的关系 158
25. 35S标记重组人GAD65抗原检测糖尿病患者GAD-Ab指数 162
26.老年妇妇体重指数与骨密度和骨超声传导速度的相关性研究 167
27.小剂量17β雌二醇对去卵巢大鼠松质骨的作用 171
28.谷氨酸脱羧酶抗体水平对两种LADA亚型的识别 173
29.羧基肽酶-H抗体对成人隐匿性自身免疫糖尿病的诊断意义 177
30.17β-雌二醇对不同时期去卵巢SD大鼠离体骨微损伤影响的观察 183
31.尼尔雌醇皮埋剂对去卵巢大鼠骨强度的影响 187
32.复方尼尔雌醇片预防去卵巢大鼠骨质疏松的实验研究 191
33.磺脲炎降糖药继发失效患者中成人隐匿性自身免疫性糖尿病的患病率调查 195
34.特发性1型糖尿病 199
35.人成骨肉瘤MG-63细胞雌激素相关基因的分离 203
36.骨质疏松研究的现状与展望 207
37.雌、孕激素与骨质疏松 210
38.完全弗氏佐剂预防非肥胖糖尿病鼠胰岛炎和糖尿病的效应 213
39.谷氨酸脱羧酶预防NOD小鼠胰岛炎的机制 217
40.NOD小鼠胰岛β细胞调亡及完全弗氏佐剂的预防效应 219
41.雌二醇对人成骨样细胞模型基质金属蛋白酶1的影响 223
42.尼尔雌醇加孕激素治疗绝经后骨质疏松症的研究 225
43.雌性人鼠全身骨密度与腰椎骨密度的一致性研究 229
44.破骨细胞及其调节机制的某些进展 232
45.绝经后妇女椎体骨骼大小对骨密度和诊断骨质疏松的影响 236
46.女性2型糖尿病患者与健康人骨密度的比较 240
47.女性不同绝经年龄骨密度和骨强度256例分析 243
48.西布曲明对肥胖糖脂代谢异常的治疗作用 246
49.脂质体与完全弗氏佐剂预防NOD鼠胰岛炎探讨 248
50.NOD小鼠胰岛分离与纯化的方法研究 251
51.完全弗氏佐剂诱导脾脏T淋巴细胞调亡预防非肥胖性糖尿病鼠1型糖尿病 254
52.人成骨细胞体外培养、鉴定及护骨素表达的研究 257
53.雌二醇对成骨细胞护骨素基因表达的影响 261
54.孕激素对人成骨样细胞膜型基质金属蛋白酶-1表达和明胶酶-A激活的影响 265
55.大鼠椎骨骨计量学与生物力学的相关研究 269
56.雌二醇与抗坏血酸对成骨细胞的协同作用 272
57.去卵巢大鼠骨质疏松凋亡细胞及其相关因素观察 277
58.人成骨肉瘤MG-63细胞分化特性及分化过程中的基因表达 280
59.女性不同骨骼部位峰值骨密度的变异度及其对诊断骨质疏松的影响 284
60.原发性醛固酮增多症的分型、定侧诊断 288
61.去卵巢SD大鼠骨丢失膜型研究 291
62.LADA与2型糖尿病患者的临床对比 294
63.激光共聚焦显微镜在骨质疏松中的应用 297
64.雌二醇对人成骨样细胞基质金属蛋白酶及期抑制因子的作用 300
65.DXA测量骨密度的精密度的评价及去卵巢鼠骨丢失敏感区的选择 304
66.对中国长沙地区女性骨密度情况的调查 308
67.雌二醇对人成骨肉瘤MG63细胞株护骨素、护骨素配体及其相关因子的调节 313